Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V (Open House Model)

GermanyTenders notice for Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V (Open House Model). The reference ID of the tender is 97503965 and it is closing on 01 Feb 2025.

100% Secure Payments

Tender Details

  • Country: Germany
  • Summary: Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V (Open House Model)
  • DET Ref No: 97503965
  • Deadline: 01 Feb 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 115200-2024
  • Purchaser's Detail :
  • Purchaser : AOK - THE HEALTH INSURANCE FUND IN HESSEPOSTAL ADDRESS: KOELNER STR. 8, 65760 ESCHBORNCOUNTRY: GERMANYCONTACT POINT(S): E.G. ATTN. MS. CORINNA VARELMANNE-MAIL: AM-VERTRAGSTEAM@HE.AOK.DE TELEPHONE: 49 61964069711FAX: 49 6966816559711INTERNET ADDRESS(ES):MAIN ADDRESS: HTTP://WWW.AOK.DE/HESSEN/
    Town: Eschborn
    NUTS-Code: DE712
    Postal Code: 65760
    Phone: 4961964069711
    Email :am-vertragsteam@he.aok.de

  • Description :
  • The subject of this publication is the conclusion of agreements in accordance with Section 130 a Paragraph 8 SGB V on finished medicinal products with different active ingredients or combinations of active ingredients within the framework of a so-called "open house model".
    Joining or concluding a contract can be done at any time and at the same timehen conditions. Individual contract negotiations will not be carried out.
    The earliest contract start date is April 1st, 2024. Based on this, the contract term is a maximum of 12 months. The contract ends on March 31, 2025, regardless of the start of the contract. Should the AOK HessIf a tender for exclusive contracts is carried out in the form of an open procedure during the contract period for the active ingredients, the contracts concluded within the framework of this publication will be terminated in accordance with the contractual provisions.
    Rivaroxaban (ATC B01AF01)
    Subject to aUniform contractual conditions and a uniform access procedure will allow all suitable and interested pharmaceutical companies or communities of pharmaceutical companies to conclude or join a discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredients mentionedoffered. Interested pharmaceutical companies can request the participation documents and the contract from the contact address (am-vertragsteam@he.aok.de). The prerequisite for concluding a contract is that the interested pharmaceutical company has the requested participation...
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
GermanyTenders Features

GermanyTenders Features

Fresh and verified Tenders from Germany. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Germany in your email inbox.

  Chat with us